CERVOMED INC. - COMMON STOCK
8.4900
09-5月-25 16:45:00
15 分の遅延
株式
-0.4100
-4.61%
本日の幅
8.1000 - 9.1699
ISIN
N/A
ソース
NASDAQ
-
CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies
22 8 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
12 8 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed to Participate in The Canaccord Genuity 44th Annual Growth Conference
30 7 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed to Participate in the Emerging Growth Conference
17 7 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024
11 7 2024 08:51:12 提供 Nasdaq GlobeNewswire
-
CervoMed Announces Addition to Russell 2000® and Russell 3000® Indexes
24 6 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
11 6 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed to Appoint William Elder as Chief Financial Officer
20 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates
15 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
01 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed to Participate in Upcoming Investor Conferences
28 3 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
28 3 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
CervoMed to Participate in the BIO CEO and Investor Conference
21 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
07 2 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
CervoMed to Participate in the Emerging Growth Conference 67
05 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CervoMed to Participate in the Emerging Growth Conference 66
05 1 2024 08:00:00 提供 Nasdaq GlobeNewswire